PrimeRFP SCOUT · Federal Contract Recompete Brief

HHSO100201700020CPurpose of THIS modification IS to — Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc holds $-7,005,694 across 6 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 24, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Department of Health and Human Services (HHS)
Agency
Regeneron Pharmaceuticals, Inc
Recipient
Sep 24, 2027
PoP end
$-5,232,662.1
Obligated
541711
NAICS
AN13
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE
Contract numberHHSO100201700020C
AgencyDepartment of Health and Human Services (HHS)
Awarding officeBarda - Aspr / Daappo / Barda Dcma
IncumbentRegeneron Pharmaceuticals, Inc
UEIN3F9MH7E6HD6
NAICS541711

No full NAICS 541711 intel page yet. Browse NAICS intelligence

PSCAN13
Place of performanceTARRYTOWN, NY
Related solicitationBAA16100SOL00002
PoP end (current)Sep 24, 2027
Obligated$-5,232,662.1

THE PURPOSE OF THIS MODIFICATION IS TO: (1) EXTEND THE PERIOD OF PERFORMANCE is a federal NONE award for Department of Health and Human Services (HHS) held by Regeneron Pharmaceuticals, Inc. Estimated value $611.3M ($-5,232,662.1 obligated). Current period of performance ends Sep 24, 2027. Last award drew 1 bidder. Place of performance: TARRYTOWN, NY. Related solicitation BAA16100SOL00002.

THE PURPOSE OF THIS MODIFICATION IS TO: (1) EXTEND THE PERIOD OF PERFORMANCE

Recompete timing

Public
● Expiring in 362 days

Current PoP ends Sep 24, 2027 (362 days remaining). Agencies typically plan 12–18 months ahead — at 11.9 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on HHSO100201700020C? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Regeneron Pharmaceuticals, Inc — $-7,005,694 obligated across 6 awards (firm-wide, all agencies).

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HHSO100201700020C?

HHSO100201700020C (Purpose of THIS modification IS to) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $611.3M, currently held by Regeneron Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HHSO100201700020C?

Barda - Aspr / Daappo / Barda Dcma awarded HHSO100201700020C to Regeneron Pharmaceuticals, Inc.

Who is the incumbent on HHSO100201700020C?

Regeneron Pharmaceuticals, Inc is the incumbent with $-7,005,694 across 6 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2027.

When does Regeneron Pharmaceuticals, Inc’s HHSO100201700020C come up for recompete?

SCOUT tracks a period-of-performance end of Sep 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on HHSO100201700020C? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSO100201700020C